Development of a Novel Helicase Assay Using Electrochemiluminescence

2001 ◽  
Vol 293 (1) ◽  
pp. 31-37 ◽  
Author(s):  
Litao Zhang ◽  
Geoffrey Schwartz ◽  
Mike O'Donnell ◽  
Richard K. Harrison
Keyword(s):  
Helicase Assay

scholarly journals A fluorescence-based helicase assay: application to the screening of G-quadruplex ligands

2015 ◽  
Vol 43 (11) ◽  
pp. e71-e71 ◽  
Author(s):  
O. Mendoza ◽  
N. M. Gueddouda ◽  
J.-B. Boule ◽  
A. Bourdoncle ◽  
J.-L. Mergny
Keyword(s):  
G Quadruplex ◽  
Helicase Assay

scholarly journals DnaB helicase is recruited to the replication initiation complex via binding of DnaA domain I to the lateral surface of the DnaB N-terminal domain

2020 ◽  
Vol 295 (32) ◽  
pp. 11131-11143 ◽  
Author(s):  
Chihiro Hayashi ◽  
Erika Miyazaki ◽  
Shogo Ozaki ◽  
Yoshito Abe ◽  
Tsutomu Katayama
Keyword(s):  
Binding Site ◽  
Lateral Surface ◽  
Replication Initiation ◽  
Terminal Domain ◽  
Dnab Helicase ◽  
Functionally Impaired ◽  
Helicase Assay ◽  
Domain Iii ◽  
Domain I

The DNA replication protein DnaA in Escherichia coli constructs higher-order complexes on the origin, oriC, to unwind this region. DnaB helicase is loaded onto unwound oriC via interactions with the DnaC loader and the DnaA complex. The DnaB–DnaC complex is recruited to the DnaA complex via stable binding of DnaB to DnaA domain I. The DnaB–DnaC complex is then directed to unwound oriC via a weak interaction between DnaB and DnaA domain III. Previously, we showed that Phe46 in DnaA domain I binds to DnaB. Here, we searched for the DnaA domain I–binding site in DnaB. The DnaB L160A variant was impaired in binding to DnaA complex on oriC but retained its DnaC-binding and helicase activities. DnaC binding moderately stimulated DnaA binding of DnaB L160A, and loading of DnaB L160A onto oriC was consistently and moderately inhibited. In a helicase assay with partly single-stranded DNA bearing a DnaA-binding site, DnaA stimulated DnaB loading, which was strongly inhibited in DnaB L160A even in the presence of DnaC. DnaB L160A was functionally impaired in vivo. On the basis of these findings, we propose that DnaB Leu160 interacts with DnaA domain I Phe46. DnaB Leu160 is exposed on the lateral surface of the N-terminal domain, which can explain unobstructed interactions of DnaA domain I–bound DnaB with DnaC, DnaG primase, and DnaA domain III. We propose a probable structure for the DnaA–DnaB–DnaC complex, which could be relevant to the process of DnaB loading onto oriC.

Amidinoanthracyclines – a new group of potential anti-hepatitis C virus compounds

2009 ◽  
Vol 390 (4) ◽  
Author(s):  
Mariusz Krawczyk ◽  
Malgorzata Wasowska-Lukawska ◽  
Irena Oszczapowicz ◽  
Anna M. Boguszewska-Chachulska
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chemical Structure ◽  
Hydroxyl Group ◽  
Current Therapy ◽  
Helicase Activity ◽  
Double Stranded Dna ◽  
Helicase Assay ◽  
Dna Substrate ◽  
Selection Of

Abstract Hepatitis C virus (HCV) infections represent one of the major and still unresolved health problems because current therapy is effective in only 50–80% of cases, depending on viral genotype. A large group of amidinoanthracyclines, with decreased acute toxicity and cardiotoxicity compared to the parent antibiotics, was tested in a high-throughput fluorometric HCV helicase assay. Here, we report the selection of more than 50 potent inhibitors of helicase activity that inhibit the enzyme with IC50 values in the range of 0.03–10 μm; four of these compounds are the most potent inhibitors of helicase activity described in the literature. The activity of these inhibitors is highly dependent on their chemical structure, mainly on the substituent at the amidino carbon atom and on the orientation of the hydroxyl group at the 4′ position of the daunosamine moiety. The most effective compounds act not solely via intercalation into the double-stranded DNA substrate, but also compete with the enzyme for access to the substrate, impeding formation of the active helicase complex. Selected amidinoanthracyclines were tested in the subgenomic HCV replicon system. These experiments confirmed the antiviral activity of two selected inhibitors (EC50 values below 0.2 μm with selectivity indices of 19 and 33) and proved that they may be considered as potential anti-HCV drugs.

scholarly journals A new helicase assay based on graphene oxide for anti-viral drug development

2013 ◽  
Vol 35 (4) ◽  
pp. 269-273 ◽  
Author(s):  
Hongje Jang ◽  
Soo-Ryoon Ryoo ◽  
Min Jae Lee ◽  
Sang Woo Han ◽  
Dal-Hee Min
Keyword(s):  
Graphene Oxide ◽  
Drug Development ◽  
Helicase Assay

scholarly journals A Helicase Assay Based on the Displacement of Fluorescent, Nucleic Acid-Binding Ligands

1996 ◽  
Vol 24 (7) ◽  
pp. 1179-1186 ◽  
Author(s):  
A. K. Eggleston ◽  
N. A. Rahim ◽  
S. C. Kowalczykowski
Keyword(s):  
Nucleic Acid ◽  
Nucleic Acid Binding ◽  
Helicase Assay

scholarly journals Inhibition of Herpes Simplex Virus Replication by a 2-Amino Thiazole via Interactions with the Helicase Component of the UL5-UL8-UL52 Complex

1998 ◽  
Vol 72 (9) ◽  
pp. 6979-6987 ◽  
Author(s):  
F. C. Spector ◽  
L. Liang ◽  
H. Giordano ◽  
M. Sivaraja ◽  
M. G. Peterson
Keyword(s):  
Herpes Simplex Virus ◽  
Herpes Simplex ◽  
Specific Inhibitor ◽  
Dna Helicase ◽  
Jurkat Cells ◽  
Single Amino Acid ◽  
Protein Marker ◽  
Helicase Assay ◽  
Simplex Virus ◽  
Primase Complex

ABSTRACT With the use of a high-throughput biochemical DNA helicase assay as a screen, T157602, a 2-amino thiazole compound, was identified as a specific inhibitor of herpes simplex virus (HSV) DNA replication. T157602 inhibited reversibly the helicase activity of the HSV UL5-UL8-UL52 (UL5/8/52) helicase-primase complex with an IC50 (concentration of compound that yields 50% inhibition) of 5 μM. T157602 inhibited specifically the UL5/8/52 helicase and not several other helicases. The primase activity of the UL5/8/52 complex was also inhibited by T157602 (IC50 = 20 μM). T157602 inhibited HSV growth in a one-step viral growth assay (IC90 = 3 μM), and plaque formation was completely prevented at concentrations of 25 to 50 μM T157602. Vero, human foreskin fibroblast (HFF), and Jurkat cells could be propagated in the presence of T157602 at concentrations exceeding 100 μM with no obvious cytotoxic effects, indicating that the window between antiviral activity and cellular toxicity is at least 33-fold. Seven independently derived T157602-resistant mutant viruses (four HSV type 2 and three HSV type 1) carried single base pair mutations in the UL5 that resulted in single amino acid changes in the UL5 protein. Marker rescue experiments demonstrated that the UL5 gene from T157602-resistant viruses conferred resistance to T157602-sensitive wild-type viruses. Recombinant UL5/8/52 helicase-primase complex purified from baculoviruses expressing mutant UL5 protein showed complete resistance to T157602 in the in vitro helicase assay. T157602 and its analogs represent a novel class of specific and reversible anti-HSV agents eliciting their inhibitory effects on HSV replication by interacting with the UL5 helicase.

Sign in / Sign up

Export Citation Format

Share Document